Together, Nanotechnology and Genetic Interference May Tackle ‘Untreatable’ Brain Tumor

February 25, 2015

(Medical Xpress) – Now a new Tel Aviv University study may offer hope to the tens of thousands diagnosed with gliomas every year. A pioneer of cancer-busting nanoscale therapeutics, Prof. Dan Peer of TAU’s Department of Department of Cell Research and Immunology and Scientific Director of TAU’s Center for NanoMedicine has adapted an earlier treatment modality—one engineered to tackle ovarian cancer tumors—to target gliomas, with promising results.